175 related articles for article (PubMed ID: 26206313)
1. Opposing roles of conventional and novel PKC isoforms in Hippo-YAP pathway regulation.
Gong R; Hong AW; Plouffe SW; Zhao B; Liu G; Yu FX; Xu Y; Guan KL
Cell Res; 2015 Aug; 25(8):985-8. PubMed ID: 26206313
[No Abstract] [Full Text] [Related]
2. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
[TBL] [Abstract][Full Text] [Related]
3. YAP controls transcriptional elongation through CKD9 recruitment for proximal pause release: "Hippo-thetical", new therapeutic targets?
Kyritsi F; Price DK; Figg WD
Cancer Biol Ther; 2016 Jun; 17(6):592-4. PubMed ID: 27149279
[TBL] [Abstract][Full Text] [Related]
4. Nuclear YAP localization as a key regulator of podocyte function.
Bonse J; Wennmann DO; Kremerskothen J; Weide T; Michgehl U; Pavenstädt H; Vollenbröker B
Cell Death Dis; 2018 Aug; 9(9):850. PubMed ID: 30154411
[TBL] [Abstract][Full Text] [Related]
5. Hippo signaling dysfunction induces cancer cell addiction to YAP.
Han H; Yang B; Nakaoka HJ; Yang J; Zhao Y; Le Nguyen K; Bishara AT; Mandalia TK; Wang W
Oncogene; 2018 Dec; 37(50):6414-6424. PubMed ID: 30068939
[TBL] [Abstract][Full Text] [Related]
6. Energy stress regulates hippo-YAP signaling involving AMPK-mediated regulation of angiomotin-like 1 protein.
DeRan M; Yang J; Shen CH; Peters EC; Fitamant J; Chan P; Hsieh M; Zhu S; Asara JM; Zheng B; Bardeesy N; Liu J; Wu X
Cell Rep; 2014 Oct; 9(2):495-503. PubMed ID: 25373897
[TBL] [Abstract][Full Text] [Related]
7. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
[TBL] [Abstract][Full Text] [Related]
8. Regulation and role of the atypical PKC isoforms in cell survival during tumor transformation.
Moscat J; Sanz L; Sanchez P; Diaz-Meco MT
Adv Enzyme Regul; 2001; 41():99-120. PubMed ID: 11384740
[No Abstract] [Full Text] [Related]
9. Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling.
Archibald A; Al-Masri M; Liew-Spilger A; McCaffrey L
Mol Biol Cell; 2015 Oct; 26(20):3578-95. PubMed ID: 26269582
[TBL] [Abstract][Full Text] [Related]
10. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics.
Meliambro K; Wong JS; Ray J; Calizo RC; Towne S; Cole B; El Salem F; Gordon RE; Kaufman L; He JC; Azeloglu EU; Campbell KN
J Biol Chem; 2017 Dec; 292(51):21137-21148. PubMed ID: 28982981
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
[TBL] [Abstract][Full Text] [Related]
12. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
13. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes.
Wennmann DO; Vollenbröker B; Eckart AK; Bonse J; Erdmann F; Wolters DA; Schenk LK; Schulze U; Kremerskothen J; Weide T; Pavenstädt H
Cell Death Dis; 2014 Nov; 5(11):e1519. PubMed ID: 25393475
[TBL] [Abstract][Full Text] [Related]
14. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
[TBL] [Abstract][Full Text] [Related]
15. AJUBA LIM Proteins Limit Hippo Activity in Proliferating Cells by Sequestering the Hippo Core Kinase Complex in the Cytosol.
Jagannathan R; Schimizzi GV; Zhang K; Loza AJ; Yabuta N; Nojima H; Longmore GD
Mol Cell Biol; 2016 Oct; 36(20):2526-42. PubMed ID: 27457617
[TBL] [Abstract][Full Text] [Related]
16. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.
Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L
Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188
[TBL] [Abstract][Full Text] [Related]
17. The hippo pathway effector YAP regulates motility, invasion, and castration-resistant growth of prostate cancer cells.
Zhang L; Yang S; Chen X; Stauffer S; Yu F; Lele SM; Fu K; Datta K; Palermo N; Chen Y; Dong J
Mol Cell Biol; 2015 Apr; 35(8):1350-62. PubMed ID: 25645929
[TBL] [Abstract][Full Text] [Related]
18. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
19. IQGAP1 Binds to Yes-associated Protein (YAP) and Modulates Its Transcriptional Activity.
Sayedyahossein S; Li Z; Hedman AC; Morgan CJ; Sacks DB
J Biol Chem; 2016 Sep; 291(37):19261-73. PubMed ID: 27440047
[TBL] [Abstract][Full Text] [Related]
20. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
